Table 5.

Stratified Risk (95% Confidence Interval) of HPA-1a Alloimmunization and its Complications in At-Risk Populations

Population (n)
HPA-1a  NK  Negative  Negative Negative  Negative  Negative  
HLA-DRB34-1500101  NK NK  Positive  NK  Positive  Positive 
Anti–HPA-1a  NK  NK  NK  Negative  Positive at any time  Persistently positive antenatally  
Event  25,379 387  123  341  46  32  
HPA-1a negativity 1:40 (36.7-42.8)  
HPA-1a alloimmunization  1:3474-150(282-451)  1:8.4 (6.9-12.1)  1:2.8 (2.3-3.7) 
Thrombocytopenic infant4-151 1:3364-150 (250-509)  1:8.6(6.5-12.7)  1:4.9 (3.6-7.6)  1:21 (13.4-46.3)  1:2.1 (1.6-3.0)  1:1.8 (1.4-2.7)  
Severe thrombocytopenia4-153 1:11004-150 (684-2910)  1:28 (18-73)  1:15 (9.2-46.6) 1:125 (52.3-∞)  1:5.5 (3.4-14.7)  1:3.9 (2.4-9.6) 
Fetal hemorrhage  1:15,4004-150 (5240-∞)  1:385 (130-∞) 1:123 (41.7-∞)  0  1:44 (15.0-∞)  1:31 (10.6-∞) 
Population (n)
HPA-1a  NK  Negative  Negative Negative  Negative  Negative  
HLA-DRB34-1500101  NK NK  Positive  NK  Positive  Positive 
Anti–HPA-1a  NK  NK  NK  Negative  Positive at any time  Persistently positive antenatally  
Event  25,379 387  123  341  46  32  
HPA-1a negativity 1:40 (36.7-42.8)  
HPA-1a alloimmunization  1:3474-150(282-451)  1:8.4 (6.9-12.1)  1:2.8 (2.3-3.7) 
Thrombocytopenic infant4-151 1:3364-150 (250-509)  1:8.6(6.5-12.7)  1:4.9 (3.6-7.6)  1:21 (13.4-46.3)  1:2.1 (1.6-3.0)  1:1.8 (1.4-2.7)  
Severe thrombocytopenia4-153 1:11004-150 (684-2910)  1:28 (18-73)  1:15 (9.2-46.6) 1:125 (52.3-∞)  1:5.5 (3.4-14.7)  1:3.9 (2.4-9.6) 
Fetal hemorrhage  1:15,4004-150 (5240-∞)  1:385 (130-∞) 1:123 (41.7-∞)  0  1:44 (15.0-∞)  1:31 (10.6-∞) 

Abbreviation: NK, not known.

F4-150

Extrapolated from actual observations.

F4-151

Cord platelet count ≤150 × 109/L.

Based on 284 cord blood platelet counts.

F4-153

Cord platelet count, <50 × 109/L.

Close Modal

or Create an Account

Close Modal
Close Modal